... patients receiving bolus 5 ... melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.
Sep 3, 2024 · ... patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT. Bone Marrow Transplantation, 43(2):141-147.
Missing: Blood Advisory
... audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory ...
... melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group. N. BlijlevensM. Schwenkglenks +12 authors. S ...
... audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory ...
Toxicity of the oral and gastrointestinal mucosa induced by high-dose melphalan is a clinical challenge with no documented prophylactic interventions or ...
patients receiving high-dose melphalan or BEAM conditioning chemotherapy—European Blood and Marrow Transplantation Mucositis. Advisory Group. J Clin Oncol ...
Jun 15, 2019 · ... patients receiving high-dose melphalan or. BEAM conditioning chemotherapy--European Blood and Marrow. Transplantation Mucositis Advisory Group.
Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European blood and marrow ...
In order to show you the most relevant results, we have omitted some entries very similar to the 19 already displayed.
If you like, you can repeat the search with the omitted results included. |